Hypertension in Pregnancy - NEET PG Revision

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/20

flashcard set

Earn XP

Description and Tags

High-yield vocabulary and core concepts for NEET PG review on hypertensive disorders of pregnancy, including diagnostic thresholds, pharmacology, complications, and management protocols.

21 Terms

1
New cards

Chronic hypertension in pregnancy

Hypertension present prior to pregnancy, diagnosed before 20 weeks20\text{ weeks} of gestation, or persisting beyond 12 weeks12\text{ weeks} postpartum.

2
New cards

Gestational hypertension

New blood pressure elevation with systolic BP ≥140 mmHg\ge 140\text{ mmHg} and/or diastolic BP ≥90 mmHg\ge 90\text{ mmHg} arising after 20 weeks20\text{ weeks} of gestation without proteinuria or maternal end-organ dysfunction.

3
New cards

Preeclampsia

New-onset hypertension presenting after 20 weeks20\text{ weeks} of gestation accompanied by proteinuria or evidence of maternal end-organ dysfunction; proteinuria is not mandatory for diagnosis when end-organ features exist.

4
New cards

Preeclampsia superimposed on chronic hypertension

Pre-existing chronic hypertension accompanied by new-onset proteinuria, a sudden worsening of blood pressure or proteinuria, or the emergence of new maternal end-organ dysfunction.

5
New cards

Eclampsia

New-onset generalized seizures occurring in a patient with preeclampsia that are not attributable to other neurological causes.

6
New cards

Severe-range blood pressure in pregnancy

Systolic blood pressure ≥160 mmHg\ge 160\text{ mmHg} and/or diastolic blood pressure ≥110 mmHg\ge 110\text{ mmHg}, requiring urgent hospital confirmation and prompt medical intervention.

7
New cards

Diagnostic proteinuria criteria in preeclampsia

Urinary protein excretion of ≥300 mg\ge 300\text{ mg} in a 24-hour24\text{-hour} urine collection, a urine protein/creatinine ratio ≥0.3\ge 0.3, or a dipstick measurement of 2+2+ when quantitative tests are unavailable.

8
New cards

Non-proteinuric preeclampsia end-organ criteria

Diagnostic criteria enabling preeclampsia diagnosis without proteinuria in a hypertensive woman: platelets <100,000/μL< 100{,}000/\mu\text{L}, serum creatinine >1.1 mg/dL> 1.1\text{ mg/dL} (or doubling of baseline), transaminases ≥2×\ge 2\times upper limit of normal or severe persistent epigastric/RUQ pain, pulmonary edema, or new cerebral/visual symptoms.

9
New cards

Pathophysiology of preeclampsia

Defective trophoblast invasion causing incomplete remodeling of spiral arteries into low-resistance vessels, leading to high-resistance uteroplacental circulation, placental ischemia, release of anti-angiogenic factors (elevated sFlt-1 and soluble endoglin; reduced free VEGF and PlGF), and widespread maternal endothelial injury.

10
New cards

Low-dose aspirin prophylaxis

Preventive regimen of 75–150 mg75\text{--}150\text{ mg} orally once daily initiated at 12 weeks12\text{ weeks} (ideally prior to 16 weeks16\text{ weeks}) in pregnant individuals identified as high-risk or with qualifying moderate-risk factors.

11
New cards

First-line maintenance antihypertensives in pregnancy

Oral medications used for the routine management of chronic or non-severe gestational hypertension, specifically oral labetalol, nifedipine, or methyldopa.

12
New cards

Contraindicated antihypertensives in pregnancy

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), which are contraindicated during pregnancy due to fetotoxicity; atenolol is avoided due to an association with fetal growth restriction.

13
New cards

Acute severe hypertension therapy in pregnancy

Urgent hospital therapies indicated for severe-range blood pressure (≥160/110 mmHg\ge 160/110\text{ mmHg}), consisting of IV labetalol, IV hydralazine, or oral immediate-release nifedipine (sublingual nifedipine is avoided).

14
New cards

Magnesium sulfate (MgSO4\text{MgSO}_4)

The drug of choice for the prevention and treatment of eclamptic seizures; acts as an anticonvulsant, not an antihypertensive agent.

15
New cards

Pritchard regimen

An eclampsia protocol consisting of an initial loading dose of 4 g IV4\text{ g IV} slowly plus 10 g IM10\text{ g IM} (5 g5\text{ g} in each buttock), followed by maintenance doses of 5 g IM5\text{ g IM} every 4 hours4\text{ hours} alternating buttocks.

16
New cards

Zuspan regimen

An intravenous magnesium sulfate regimen consisting of a 4 g IV4\text{ g IV} loading dose followed by a continuous infusion of 1–2 g/hour1\text{--}2\text{ g/hour}.

17
New cards

Magnesium sulfate safety monitoring parameters

Clinical assessments required prior to each maintenance dose: presence of the patellar reflex (knee jerk), maternal respiratory rate ≥12/min\ge 12/\text{min}, and urinary output ≥25–30 mL/hour\ge 25\text{--}30\text{ mL/hour}.

18
New cards

Calcium gluconate antidote

The specific antidote for magnesium sulfate toxicity, administered as 1 g IV1\text{ g IV} (10 mL10\text{ mL} of a 10%10\% solution) slowly to reverse loss of deep tendon reflexes, respiratory depression, or cardiac arrest.

19
New cards

Delivery timing in preeclampsia

Definitive management recommended at 37 weeks37\text{ weeks} for gestational hypertension or preeclampsia without severe features, and at ≥34 weeks\ge 34\text{ weeks} following maternal stabilization in preeclampsia with severe features (or any gestational age upon clinical deterioration).

20
New cards

HELLP syndrome

A severe preeclampsia variant characterized by the triad of Hemolysis, Elevated Liver enzymes, and Low Platelets.

21
New cards

Tennessee criteria

Diagnostic laboratory thresholds for complete HELLP syndrome: total LDH ≥600 IU/L\ge 600\text{ IU/L}, AST ≥70 IU/L\ge 70\text{ IU/L}, and platelet count <100,000/μL< 100{,}000/\mu\text{L}.